Gujarat-based company Senorus Pharma aims to raise Rs 582 crore. Retail investors had to invest a minimum of Rs 14,858 with a lot size of 38 equity shares.
The company’s shares are scheduled to be listed on BSE and NSE on December 30. (Rep/Shutterstock)
The initial public offering (IPO) of Gujarat-based pharmaceutical company Senorus Pharma closed on December 24 after a four-day subscription period that began on December 20. . The company aims to raise Rs 582 crore through the offering, having already secured Rs 260.6 crore from anchor investors.
In the gray market, shares of Senores Pharma are trading at a premium of Rs 230. This represents a 58.8% premium over their issue price. Based on the current premium, the company’s shares could be listed in the market at around Rs 621. A gray market is an unauthorized market where shares of a company are traded before their official listing. Market experts caution that investment decisions should be based on a company’s financial health rather than signals from the gray market.
IPO price band: Rs 372-391 per share
The price band for this IPO has been fixed at Rs 372-391 per share. The company’s shares are scheduled to be listed on BSE and NSE on December 30. The minimum investment amount for retail investors was Rs 14,858, representing a lot size of 38 equity shares.
The business of Senorus Pharmaceuticals
Senores Pharmaceuticals’ business is primarily focused on the regulated markets of the US, Canada and the UK, while maintaining a presence in the emerging markets of 43 countries.
(Disclaimer: Investments made in IPO are subject to market risks. If you want to invest money, consult a certified investment advisor first. News18 will not be responsible for any profit or loss. ).